The role of anti-tumor immunity of focused ultrasound for the malignancies: depended on the different ablation categories Luping ZhangChao YangWenzhi Chen Review Article 09 August 2022 Pages: 1543 - 1553
Prevalence of pathogenic germline variants in the circulating tumor DNA testing Yoshihiro YamamotoKeita FukuyamaManabu Muto Original Article Open access 23 July 2022 Pages: 1554 - 1561
The tumor suppressor function of hsa_circ_0006282 in gastric cancer through PTEN/AKT pathway Zhe LiYi XieJunming Guo Original Article 07 July 2022 Pages: 1562 - 1569
Artificial intelligence predicts lymph node metastasis or risk of lymph node metastasis in T1 colorectal cancer Kenta KasaharaKenji KatsumataAkihiko Tsuchida Original Article 31 July 2022 Pages: 1570 - 1579
Fusobacterium nucleatum load in MSI colorectal cancer subtypes Tomoyuki OnoTatsuro YamaguchiShin-ichiro Horiguchi Original Article 20 July 2022 Pages: 1580 - 1588
Percutaneous cryoablation combined with prior transcatheter arterial embolization for renal cell carcinomas of 3 cm or larger: a prospective study Hideo GobaraYusuke MatsuiTakao Hiraki Original Article 09 August 2022 Pages: 1589 - 1595
Real-world efficacy and safety of nivolumab plus ipilimumab in untreated metastatic renal cell carcinoma, and the impact of previous nephrectomy on clinical outcome: Japanese multi-institutional retrospective study Taigo KatoKazutoshi FujitaNorio Nonomura Original Article 13 July 2022 Pages: 1596 - 1604
Diagnostic performance of fluorescence in situ hybridization (FISH) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis Amir Hossein AalamiFarnoosh Aalami Original Article 18 July 2022 Pages: 1605 - 1615
Diverting ileostomy is a risk factor for renal impairment during CAPOX therapy Kazuaki OkamotoHiroaki NozawaSoichiro Ishihara Original Article 22 July 2022 Pages: 1616 - 1623
Surgical and functional outcomes of robot-assisted laparoscopic partial nephrectomy for renal cell carcinoma in adolescents and young adults: a propensity score matching study Kazuhiko YoshidaTsunenori KondoToshio Takagi Original Article 25 July 2022 Pages: 1624 - 1631
Health-related quality of life with enzalutamide versus flutamide in castration-resistant prostate cancer from the AFTERCAB study Hiroji UemuraKazuki KobayashiSeiji Naito Original Article Open access 10 August 2022 Pages: 1632 - 1643
Efficacy and safety of olaparib maintenance monotherapy for Japanese patients with platinum-sensitive relapsed ovarian, fallopian tube, and primary peritoneal cancer Tomoko YoshihamaYuka KurodaDaisuke Aoki Original Article 15 July 2022 Pages: 1644 - 1650
Change of HPV vaccination rates in Japan: the effect of individual notifications implemented by local governments Asami YagiYutaka UedaTadashi Kimura Original Article 25 July 2022 Pages: 1651 - 1659
Who are the long-term survivors of recurrent ovarian carcinoma?: a retrospective analysis of a multicenter study Masato YoshiharaKazumasa MogiHiroaki Kajiyama Original Article 30 July 2022 Pages: 1660 - 1668